Last reviewed · How we verify
NCT06621745
A Gratitude Intervention App to Reduce Symptoms of Depression, Anxiety and Stress
NA trial testing Gratitude Intervention App in Depression in 157 participants. Completed in 14 April 2023.
14 April 2023
Quick facts
| Lead sponsor | Dalhousie University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 157 |
| Start date | 3 November 2021 |
| Primary completion | 14 April 2023 |
| Estimated completion | 14 April 2023 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Gratitude Intervention App
Conditions studied
- Depression — all drugs for Depression →
- Anxiety — all drugs for Anxiety →
- Stress — all drugs for Stress →
Sponsor
Dalhousie University
Who can join
Adults 18 to 30, any sex, with Depression or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to examine whether a newly developed gratitude intervention app can effectively improve psychological functioning, as measured by depression, anxiety, and stress symptoms, positive and negative affect The main questions it aims to answer are: 1\. Will people who are in the intervention group feel more positive emotions and experience fewer negative emotions such as stress, anxiety, and depression after three weeks? Researchers will compare the intervention to a control group (a group not given the gratitude intervention) to see if the intervention works to improve psychological functioning. Participants will: * Complete an online survey on emotional well-being and personality traits at the beginning and end of the three-week study, with daily mood ratings and stress assessments every three days. * Participants in the intervention group will use a mobile app to practice gratitude exercises.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06621745
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Other Dalhousie University trials
Trials by the same sponsor.
- NCT07305207 — Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness · Phase 1 · not yet recruiting
- NCT06827470 — Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis · Phase 1 · recruiting
- NCT06777277 — Cognitive-Behavioural Couple Therapy for Sexual Interest/Arousal Disorder · NA · recruiting
- NCT06211972 — The Feasibility of the OpiVenture Program for Clients Undergoing Opioid Agonist Therapy · NA · not yet recruiting
- NCT06588049 — Nitrate Mouth Rinse and the Oral Microbiome · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06621745 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dalhousie University
- Last refreshed: 1 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06621745.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing